Lipocalin-2 in Stroke

Crossmark: check for updates

Authors

  • Wen-Hai Chou
  • Yi-Chinn Weng
  • Varun Kumar

DOI:

https://doi.org/10.17140/NOJ-2-109

Keywords:

Lipocalin-2; NGAL; 24p3; Stroke; Reperfusion injury; Neutrophil; PKC; Phosphorylation; Biomarker.

Abstract

Stroke is a leading cause of adult disability in the United States. However, limited
number of molecularly targeted therapy exists for stroke. Recent studies have shown that Lipocalin-2 (LCN2) is an acute phase protein mediating neuroinflammation after ischemic and
hemorrhagic strokes. This review is an attempt to summarize some LCN2-related research findings and discuss its role in stroke.

References

Lees KR. Management of acute stroke. Lancet Neurol. 2002; 1: 41-50. doi: 10.1016/S1474-4422(02)00005-4

Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: A report from the American heart association. Circulation. 2015; 131: e29-e322. doi: 10.1161/ CIR.0000000000000152

van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007; 369: 306-318.

Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemor-rhage. Lancet. 2009; 373: 1632-1644.

Rincon F, Mayer SA. Intracerebral hemorrhage: Clinical over-view and pathophysiologic concepts. Transl Stroke Res. 2012; 3: 10-24. doi: 10.1007/s12975-012-0175-8

Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: Mecha-nisms of injury and therapeutic targets. Lancet Neurol. 2012; 11: 720-731. doi: 10.1016/S1474-4422(12)70104-7

Al-Khoury L, Lyden PD. Intravenous thrombolysis. In: Moore JP, Choi DW, Grotta JC, Weir B, Wolf PA, eds. Stroke: Pathophysiology, diagnosis, and management. Churchill Liv-ingstone, New York: Elsevier Inc. 2004; 919-941.

Iadecola C, Anrathe J. The immunology of stroke: From mechanisms to translation. Nat Med. 2011; 17: 796-808. doi: 10.1038/nm.2399

Chou WH, Messing RO. Protein kinase c isozymes in stroke. Trends Cardiovasc Med. 2005; 15: 47-51. doi: 10.1016/j. tcm.2005.01.003

Chou WH, Choi DS, Zhang H, et al. Neutrophil protein ki-nase cdelta as a mediator of stroke-reperfusion injury. J Clin In-vest. 2004; 114: 49-56. doi: 10.1172/JCI21655

Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med. 2011; 17: 1391-1401. doi: 10.1038/nm.2507

Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: Pathophysiology and role of in-flammatory mediators. FEBS J. 2009; 276: 13-26. doi: 10.1111/ j.1742-4658.2008.06766.x

Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta. 2000; 1482: 272-283. doi: 10.1016/S0167-4838(00)00152-7

Allen JJ, Li M, Brinkworth CS, et al. A semisynthetic epitope for kinase substrates. Nat Methods. 2007; 4: 511-516. doi: 10.1038/nmeth1048

Kumar V, Weng YC, Geldenhuys WJ, et al. Generation and characterization of atp analog-specific protein kinase cdelta. J Biol Chem. 2015; 290: 1936-1951. doi: 10.1074/jbc. M114.598698

Weng YC, Wang G., Messing RO, Chou WH. Identification of lipocalin-2 as a pkc delta phosphorylation substrate in neu-trophils. Journal of Biomedical Science (in press). 2015. doi: 10.1186/s12929-015-0129-z

Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lind-garde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with isch-emic cerebrovascular diseases. Stroke. 1996; 27: 1734-1738. doi: 10.1161/01.STR.27.10.1734

Anwaar I, Gottsater A, Ohlsson K, Mattiasson I, Lindgarde F. Increasing levels of leukocyte-derived inflammatory media-tors in plasma and camp in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis. 1998; 8: 310-317.

Falke P, Elneihoum AM, Ohlsson K. Leukocyte activa-tion: Relation to cardiovascular mortality after cerebrovas-cular ischemia. Cerebrovasc Dis. 2000; 10: 97-101. doi: 10.1159/000016037

Chiang T, Messing RO, Chou WH. Mouse model of mid-dle cerebral artery occlusion. J Vis Exp. 2011; 13(48). doi: 10.3791/2761

Jin M, Kim JH, Jang E, et al. Lipocalin-2 deficiency attenu-ates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab. 2014; 34(8): 1306-1314. doi: 10.1038/jcbfm.2014.83

Xing C, Wang X, Cheng C, et al. Neuronal production of lipocalin-2 as a help-me signal for glial activation. Stroke. 2014; 45: 2085-2092. doi: 10.1161/STROKEAHA.114.005733

Wang G, Weng YC, Han X, Whaley JD, McCrae KR, Chou WH. Lipocalin-2 released in response to cerebral ischaemia me-diates reperfusion injury in mice. J Cell Mol Med. 2015. doi: 10.1111/jcmm.12538

Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Ex-pansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. A sci-ence advisory from the american heart association/american stroke association. Stroke. 2009; 40: 2945-2948. doi: 10.1161/ STROKEAHA.109.192535

Kidwell CS, Latour L, Saver JL, et al. Thrombolytic toxicity: Blood brain barrier disruption in human ischemic stroke. Cere-brovasc Dis. 2008; 25: 338-343. doi: 10.1159/000118379

Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reac-tive astrogliosis. J Neurosci. 2012; 32: 6391-6410. doi: 10.1523/ JNEUROSCI.6221-11.2012

Schroll A, Eller K, Feistritzer C, et al. Lipocalin-2 amelio-rates granulocyte functionality. Eur J Immunol. 2012; 42: 3346- 3357. doi: 10.1002/eji.201142351

Bi F, Huang C, Tong J, et al. Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci USA. 2013; 110: 4069-4074. doi: 10.1073/pnas.1218497110

Dong M, Xi G, Keep RF, Hua Y. Role of iron in brain lipoc-alin 2 upregulation after intracerebral hemorrhage in rats. Brain Res. 2013; 1505: 86-92. doi: 10.1016/j.brainres.2013.02.008

Egashira Y, Hua Y, Keep RF, Xi G. Acute white matter in-jury after experimental subarachnoid hemorrhage: Potential role of lipocalin 2. Stroke. 2014; 45: 2141-2143. doi: 10.1161/ STROKEAHA.114.005307

Yang J, Goetz D, Li JY, et al. An iron delivery pathway medi-ated by a lipocalin. Mol Cell. 2002; 10: 1045-1056. doi: 10.1016/ S1097-2765(02)00710-4

Devireddy LR, Gazin C, Zhu X, Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell. 2005; 123: 1293-1305. doi: 10.1016/j. cell.2005.10.027

Devireddy LR, Hart DO, Goetz DH, Green MR. A mam-malian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. 2010; 141: 1006-1017. doi: 10.1016/j.cell.2010.04.040

Wu L, Du Y, Lok J, Lo EH, Xing C. Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms. J Neurochem. 2015; 132: 622-628. doi: 10.1111/jnc.13023

Published

2015-04-17

How to Cite

Wen-Hai Chou, Yi-Chinn Weng, & Varun Kumar. (2015). Lipocalin-2 in Stroke. Neuro, 2(1), 38–41. https://doi.org/10.17140/NOJ-2-109

Issue

Section

Articles